The growth of the vancomycin market is driven by several key factors, including the increasing prevalence of antibiotic-resistant infections, advancements in pharmaceutical manufacturing ...

Vancomycin 265/309 (85.8% ... In general, strive to use antibiotics covering a spectrum no broader than necessary and narrow the antibiotic spectrum of treatment after results of cultures and ...

Following treatment of acute rejection with pulsed intravenous methylprednisolone and an increase in his cyclosporine ... liver histology following use of this antibiotic in patients with ...

Cefazolin* (Ancef) 2 g IV initial dose then 1 g IV every 8 h ... allergic and GBS resistant to clindamycin and erythromycin ‡ Vancomycin 1 g IV every 12 h until delivery GBS = Group B ...

You may have heard of antibiotic-resistant bacterial infections, which are challenging to treat. Methicillin-resistant ...

When the pain became unmanageable, Maloney opted to have her back surgically repaired at HCA Florida North Florida Hospital ...

(Clostridioides difficile) is bacteria that causes about 500,000 infections a year in the United States, according to the U.S ...

Seek emergency care if symptoms like these develop. Cellulitis is usually treated with intravenous antibiotics. You may also need pain medication such as ibuprofen to treat pain and fever. Necrotizing ...

Subsequent review of the patient's medication list revealed that the he had been on linezolid for 6 weeks for the treatment of vancomycin-resistant Enterococcus fecalis bacteremia. Investigations.

CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West ...

Dec 16 (Reuters) - Merck (MRK.N), opens new tab said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials. The pharmaceutical giant ...